Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02570321 · ClinicalTrials.gov registry record · Phase 3
Cross-linking for Corneal Ulcers Treatment Trial
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 147
- Enrollment target
NCT02570321 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 147 participants.
The verdict
NCT02570321, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 147 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if patients randomized to corneal collagen cross-linking plus medical therapy will have a lower prevalence of positive bacterial or fungal cultures immediately after the procedure than patients who received medical therapy alone. The secondary purpose of this study is to determine if patients randomized to corneal collagen cross-linking will have a better visual acuity at 3 and 12 months than patients who receive medical therapy alone.
Interventions
- PROCEDURE Corneal Cross-linking
- DRUG Anti Fungal Drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-03-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02570321
The ClinicalTrials.gov registry entry for NCT02570321 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Corneal Cross-linking is the first listed.
NCT02570321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02570321 about?
NCT02570321 is a clinical study titled "Cross-linking for Corneal Ulcers Treatment Trial". The primary purpose of this study is to determine if patients randomized to corneal collagen cross-linking plus medical therapy will have a lower prevalence of positive bacterial or fungal cultures immediately after the procedure than patients who received medical therapy alone. The secondary purpo...
What is the current status of trial NCT02570321?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 147 participants. The study started on 2015-11. Estimated completion is 2019-03-19.
What interventions are being tested in trial NCT02570321?
The interventions under investigation include: Corneal Cross-linking (PROCEDURE), Anti Fungal Drug (DRUG).
Who is sponsoring clinical trial NCT02570321?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.